Healthcare -
Biotechnology - NASDAQ - US
$ 5.4
9.09 %
$ 46.3 M
Market Cap
-0.39
P/E
KPTI - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities KPTI - Karyopharm Therapeutics Inc.
41.6 M
LAST VALUE
-53.64%
2 YEAR CAGR
-19.64%
5 YEAR CAGR
-9.51%
10 YEAR CAGR